secwatch.observer — SEC 8-K summary
======================================

Issuer:     Perspective Therapeutics, Inc. (CATX)
CIK:        0000728387
Form:       8-K
Filed at:   2023-12-06T23:59:59+00:00
Accession:  0001437749-23-033769
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Perspective Therapeutics unit enters Cesium-131 supply deal with Russian state firm through March 2025
--------------------------------------------------------------------------------

- Isoray Medical signed contract with JSC Isotope for Cesium-131; supersedes November 2022 agreement.
- Contract effective January 1, 2024 through March 31, 2025; price and volume redacted as confidential.
- Buyer agrees Russian sanctions do not excuse performance; dispute resolution under Hong Kong law/HKIAC.
- Payment due 30 calendar days after delivery in USD via intermediary bank; shipping FCA Russia.
- Goods restricted to medical source production; no military use; seller may inspect end-use compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/728387/000143774923033769/0001437749-23-033769-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/728387/000143774923033769/isr20231205_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-033769

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer